HEIQ, onye ndu zuru ụwa ọnụ na mmepụta akwa na ihe ọhụrụ, ewepụtala HEIQ Metalliq, ihe nkpuchi nke nwere ike ịchọpụta ma mebie nje na nje bacteria. Ihe nkpuchi, nke na-eji ihe eji eme ihe, nwere n'ezie mkpuchi dị nro nke ọla kọpa dị ọcha agbakwunyere site na a. Usoro ntinye uzuoku dị elu nke a na-akpọ Heiq Metallix, nke na-agbanwe ntakịrị ọla kọpa ka ọ bụrụ vepo nke a na-edobere n'elu eriri.

HEIQ Metallix bụ teknụzụ na-echere patent nke onye mmekọ ọhụrụ HEIQ mepụtara, ụlọ ọrụ teknụzụ ihe Australia XEFCO. Nnyocha nke Peter Doherty Institute of Infection and Immunity mere na Melbourne, Australia, gosiri na akwa ejiri teknụzụ Heiq Metallix mesoo nwere ike mebie ọrịa na-efe efe nke ukwuu. novel coronavirus n'ime naanị nkeji 5. Atụmatụ nnwale ahụ na-egosipụta mmekọrịta dị adị nke ikuku ikuku na-emerụ ngwaahịa textile dị ka ihe mkpuchi ihu. A na-ekpughere ihe nlele ọ bụla n'ebu ibu Coronavirus dị elu, sochiri 5, 15, na 30min na-agbasa n'ime ụlọ okpomọkụ. , n'ikpeazụkwa, a tụrụ ọnụọgụ nje SARS-CoV-2 fọdụrụnụ. Nsonaazụ gosiri na ihe nlele akwa ejiri teknụzụ HEIQ Metallix agwọ ọrịa belatara nje ahụ karịa 97.79% n'ime 5min, 99.95% n'ime 15min, yana 99.99% n'ime 30min, ma e jiri ya tụnyere ya. na njikwa inoculation.

Ọla kọpa bụ ihe sitere n'okike na ihe a na-ahụ anya nke na-eme n'onwe ya na ụmụ mmadụ, osisi na anụmanụ. Amara ya maka antiviral na antibacterial Njirimara ruo ọtụtụ narị afọ. Ihe ndị a na-emeso ya na usoro Heiq Metallix na-ahapụ ions ọla kọpa, nke na-adịghị arụ ọrụ nje na nje bacteria. , na-egbu 100 pasent nke Staphylococcus aureus na Klebsiella pneumoniae, na ime ka 99.95 pasent nke nje H1N1 na 99.9 pasent nke coronavirus mmadụ 229E.